Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of MRG003 in advanced/metastatic gastric cancer and gastroesophageal junction carcinoma; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Gastric Cancer
• Or Metastatic Gastroesophageal Junction Carcinoma

Drugs mentioned

• MRG003

Snippet

Sponsor: Shanghai Miracogen Inc. | Conditions: Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Carcinoma | Phase 2 | Status: UNKNOWN